Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Journal of Biological Chemistry
|
February 8, 2000
HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution
Y Collette, S Arold, C Picard, et al.
International Immunology
|
November 4, 2000
Role of Tec kinase in nuclear factor of activated T cells signaling
W C Yang, M Ghiotto, R Castellano, et al.
Revue Medicale De Liege
|
April 11, 2002
[Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1]
M Polus, G Jerusalem, B Sautois, et al.
Leukemia
|
October 8, 2011
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1
H Chaib, A Nebbioso, T Prebet, et al.
The Journal of Biological Chemistry
|
March 30, 2001
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein
G Hassaïne, M Courcoul, G Bessou, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1996
Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression
Y Collette, H L Chang, C Cerdan, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents
J M Péloponèse, Y Collette, C Grégoire, et al.
Molecular and Cellular Biology
|
October 7, 2009
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn
C Brignatz, M P Paronetto, S Opi, et al.
Blood Cancer Journal
|
March 14, 2015
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
Y Collette, T Prébet, A Goubard, et al.
Blood Cancer Journal
|
March 21, 2015
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
E Saland, H Boutzen, R Castellano, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Journal of Biological Chemistry
|
February 8, 2000
HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution
Y Collette, S Arold, C Picard, et al.
International Immunology
|
November 4, 2000
Role of Tec kinase in nuclear factor of activated T cells signaling
W C Yang, M Ghiotto, R Castellano, et al.
Revue Medicale De Liege
|
April 11, 2002
[Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1]
M Polus, G Jerusalem, B Sautois, et al.
Leukemia
|
October 8, 2011
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1
H Chaib, A Nebbioso, T Prebet, et al.
The Journal of Biological Chemistry
|
March 30, 2001
The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein
G Hassaïne, M Courcoul, G Bessou, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1996
Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression
Y Collette, H L Chang, C Cerdan, et al.
The Journal of Biological Chemistry
|
April 17, 1999
Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents
J M Péloponèse, Y Collette, C Grégoire, et al.
Molecular and Cellular Biology
|
October 7, 2009
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn
C Brignatz, M P Paronetto, S Opi, et al.
Blood Cancer Journal
|
March 14, 2015
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
Y Collette, T Prébet, A Goubard, et al.
Blood Cancer Journal
|
March 21, 2015
A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
E Saland, H Boutzen, R Castellano, et al.
Page
of 4